Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative fatal disorder in which motor neurons within the brain and spinal cord degenerate. A single infusion of mesenchymal stem cells (MSCs) delays disease progression by protecting motor neurons and restoring the blood-spinal cord barrier in the SOD1G93A transgenic ALS rat model. However, the therapeutic effect of a single infusion of MSCs is transient and does not block disease progression. In this study, we demonstrated that repeated administration of MSCs (weekly, four times) increased the survival period, protected motor functions, and reduced deterioration of locomotor activity compared to a single infusion and vehicle infusion, after which rats displayed progressive deterioration of hind limb function. We also compared the days until gait ability was lost in rats and found that the repeated-infused group maintained gait ability compared to the single-infusion and vehicle-infusion groups. These results suggest that repeated administration of MSCs may prevent the deterioration of motor function and extend the lifespan in ALS.
References
Feb 1, 1995·Journal of Neurotrauma·D M BassoJ C Bresnahan
May 22, 2007·Brain Research·Svitlana Garbuzova-DavisPaul R Sanberg
Aug 2, 2007·PloS One·Masatoshi SuzukiClive N Svendsen
Nov 22, 2007·PloS One·Svitlana Garbuzova-DavisPaul R Sanberg
Mar 18, 2008·Nature Neuroscience·Zhihui ZhongBerislav V Zlokovic
Apr 13, 2010·Brain Research·Katsuya KomatsuJeffery D Kocsis
Feb 8, 2011·Lancet·Matthew C KiernanMargaret C Zoing
Feb 22, 2011·Journal of Neuroscience Research·Kazunori MiyazakiKoji Abe
Mar 5, 2014·Proceedings of the National Academy of Sciences of the United States of America·Ethan A WinklerBerislav V Zlokovic
Aug 6, 2015·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Shoichi Sasaki
Sep 3, 2016·Neuroscience·Tomonori MoritaOsamu Honmou
Apr 19, 2019·Neuroscience·Masahito NakazakiOsamu Honmou
Feb 1, 2021·Brain Research·Hirotoshi MagotaOsamu Honmou
Mar 6, 2021·Clinical Neurology and Neurosurgery·Osamu HonmouJeffery D Kocsis